HOB BIOTECH(SH:688656) Sou Hu Cai Jing·2025-03-29 02:57Company Overview - As of March 28, 2025, Haobo Bio (688656) closed at 89.0 CNY, a slight increase of 0.02% from the previous week [1] - The company's total market capitalization is 5.612 billion CNY, ranking 57th out of 124 in the medical device sector and 2625th out of 5139 in the A-share market [1] Upcoming Events - Haobo Bio will hold its 2024 Annual General Meeting on April 7, 2025, in Suzhou, Jiangsu Province [1][3] - The meeting will review several proposals, including the 2024 annual report, financial budget for 2025, and the profit distribution plan for 2024 [1][3] Financial Performance - In 2024, the company achieved total operating revenue of 402.34 million CNY, representing a year-on-year growth of 2.01% [2][3] - The net profit attributable to shareholders was 36.80 million CNY, reflecting a decline of 22.24% compared to the previous year [2][3] Profit Distribution - The profit distribution plan for 2024 includes a cash dividend of 3.0 CNY per 10 shares, totaling 18.68 million CNY [2][3] Financial Plans - The company plans to apply for a bank credit facility not exceeding 700 million CNY for 2025 and anticipates a guarantee limit of no more than 200 million CNY [2][3]